U-Blot® Research Grade RemtolumabCat. No. WA3436Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade RemtolumabCat. No. WA3436
U-Blot® Research Grade RemternetugCat. No. WA3435
U-Blot® Research Grade remigromigCat. No. WA3434
U-Blot® Research Grade RelfovetmabCat. No. WA3433
U-Blot® Research Grade RelatlimabCat. No. WA3432
U-Blot® Research Grade RegavirumabCat. No. WA3431
U-Blot® Research Grade ReflocibartCat. No. WA3430
U-Blot® Research Grade RefanezumabCat. No. WA3429
U-Blot® Research Grade Redalsomatropin AlfaCat. No. WA3428
U-Blot® Research Grade ReciferceptCat. No. WA3427
U-Blot® Research Grade recibokibartCat. No. WA3426
U-Blot® Research Grade RecaticimabCat. No. WA3425